Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Performance of a Recombinant Polymerase Amplification Test - Lateral Flow (RPA-LF) for Cutaneous Leishmaniasis in an Endemic Setting of Colombia

NCT04500873 is registered in ClinicalTrials.gov with Centro Internacional de Entrenamiento e Investigaciones Médicas as lead sponsor.

NCT NCT04500873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04500873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Performance of a Recombinant Polymerase Amplification Test - Lateral Flow (RPA-LF) for Cutaneous Leishmaniasis in an Endemic Setting of Colombia
Lead sponsor
Centro Internacional de Entrenamiento e Investigaciones Médicas
Phase
Observational
Overall status
Completed
Start date
February 1, 2018
Completion date
December 20, 2019
Enrollment
128 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous leishmaniasis (diagnosis)